The continuation of our services and the treatment of patients without disruption is our key priority. We have taken various measures and precautions since the outbreak of COVID-19 to ensure that we remain fully operational. Should our business operations encounter issues we will immediately contact all relevant stakeholders (physicians, patients, regulators, manufacturers, etc.).
We are currently in discussion with various parties to offer our assistance in helping patients access clinical trials and expanded access programs for COVID-19 treatments in development.
For now we are offering our assistance to manufacturers. Interested patients and their caregivers can reach out to manufacturers directly for questions regarding access.
For other inquiries and comments, please reach out to us via email@example.com